Webinar Alert: Bridging the Preclinical Gap with Next-Generation Brain and Tumor Organoids
For decades, translational medicine has faced a frustrating bottleneck: why do over 90% of oncology and neurology drug candidates that show dazzling success in preclinical lab testing ultimately fail when injected into human patients? The answer lies in the structural limitations of our screening models. Traditional 2D cell monolayers flat-line the natural three-dimensional spatial architecture...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek